PathXL report successful sales of Halo Software across USA and European markets
Belfast, Northern Ireland, November 10th, 2015 — PathXL have reported a successful quarter in contracting new customers on both sides of the Atlantic for a range of HALO image analysis solutions (Indica Labs, Corrales, New Mexico, USA). PathXL embarked on a global partnership with Indica Labs to resell HALO™ image analysis software in July 2014.
PathXL has announced that the quarter just completed (Q2, 2015) was highlighted by contracting with several Biopharmaceutical companies including Adaptimmune (Oxfordshire, United Kingdom), as well as a range of university research centers, such as Lund University (Lund, Sweden) and University of North Carolina (Chapel Hill, NC,USA) , who have chosen to work with PathXL to acquire HALO.
Please contact PathXL directly for further information or a free demo of HALO image analysis software.
About HALO Software
The HALO software suite is fastest, most scalable, user-friendly image analysis software for digital pathology applications, designed to improve accuracy, speed up research studies and drive quality improvements.
“Image analysis is a key requirement for today’s advanced Digital Pathology systems,” says Des Speed, CEO of PathXL. “We see great synergy between Indica Labs’ extensive portfolio of image analysis algorithms and PathXL’s Xplore platform for web based image and data management.”
By reselling the HALO suite, PathXL has further extended its ability to serve the broadest needs of the market and offer customers an end to end solution for best in class image and data management with Xplore, and the best in class image analysis with HALO.
About PathXL Ltd
PathXL is a global pioneer in the use of web-based solutions for digital pathology and provides innovative software for use in research, clinical and education applications worldwide. Taking a vendor agnostic approach to partnerships we strive to be the best in the world at what we do, while providing our customers with the most flexible, scalable and future proof solutions.
Category: Pathology News